Drug Delivery Devices Market Outlook in China to 2016 - Inhalation Systems, Infusion Systems and Others

Report Summary

GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in China to 2016 - Inhalation Systems, Infusion Systems and Others” provides key market data on the China Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories – Inhalation Systems, Needle Free Injections and Infusion Systems. Segments include Dry Powder Inhaler Devices, Metered Dose Inhaler Devices, Infusion Disposable Sets and Others. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for Drug Delivery Devices market categories – Inhalation Systems, Needle Free Injections and Infusion Systems.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. Segments include Dry Powder Inhaler Devices, Metered Dose Inhaler Devices, Infusion Disposable Sets and Others.
• 2009 company shares and distribution shares data for each of the three market categories.
• Global corporate-level profiles of key companies operating within the China Drug Delivery Devices market.
• Key players covered include GlaxoSmithKline plc, AstraZeneca International plc, Boehringer Ingelheim GmbH, Sepracor Inc., CareFusion Corporation and others.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Explore investment opportunites in the market.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7

2 Introduction 8
2.1 What is This Report About? 8

3 Drug Delivery Devices In China 9
3.1 Drug Delivery Devices, Market Segmentation 9
3.2 Drug Delivery Devices, China, Overall Revenue ($m), 2002-2016 10
3.3 Drug Delivery Devices Market, China, Revenue Mix ($m), 2009 11
3.4 Drug Delivery Devices Market, China, Category Contribution (%), 2009 12
3.5 Drug Delivery Devices, China, Category Volume (Units), 2002-2016 19
3.6 Drug Delivery Devices, China, Company Share (2008-2009) 22

4 Infusion Systems In China 24
4.1 Infusion Systems, Market Segmentation 24
4.2 Infusion Systems Market, China, Revenue Mix ($m), 2009 25
4.3 Infusion Systems Market, China, Category Contribution (%), 2009 26
4.4 Infusion Systems Overall Revenue (2002-2016) 27
4.5 Infusion Systems Overall Volume (2002-2016) 31
4.6 Infusion Systems Average Price (2002-2016) 35
4.7 Infusion Systems Distribution Share (2008-2009) 36
4.8 Infusion Systems, China, Company Share (2008-2009) 37

5 Inhalation Systems In China 39
5.1 Inhalation Systems, Market Segmentation 39
5.2 Inhalation Systems Market, China, Revenue Mix ($m), 2009 40
5.3 Inhalation Systems Market, China, Category Contribution (%), 2009 41
5.4 Inhalation Systems Overall Revenue (2002-2016) 42
5.5 Inhalation Systems Overall Volume (2002-2016) 46
5.6 Inhalation Systems Average Price (2002-2016) 50
5.7 Inhalation Systems Distribution Share (2008-2009) 51
5.8 Inhalation Systems, China, Company Share (2008-2009) 52

6 Overview of Key Companies in China Drug Delivery Devices Market 54
6.1 GlaxoSmithKline plc 54
6.1.1 Company Overview 54
6.1.2 Share in the China Drug Delivery Devices Market 54
6.2 AstraZeneca PLC 55
6.2.1 Company Overview 55
6.2.2 Share in the China Drug Delivery Devices Market 55
6.3 3M Health Care 56
6.3.1 Company Overview 56
6.3.2 Share in the China Drug Delivery Devices Market 56
6.4 Baxter International Inc. 57
6.4.1 Company Overview 57
6.4.2 Share in the China Drug Delivery Devices Market 57
6.5 Fresenius Kabi AG 58
6.5.1 Company Overview 58
6.5.2 Share in the China Drug Delivery Devices Market 58
6.6 Boehringer Ingelheim GmbH 59
6.6.1 Company Overview 59
6.6.2 Share in the China Drug Delivery Devices Market 59
6.7 NIPRO CORPORATION 60
6.7.1 Company Overview 60
6.8 Terumo Corporation 60
6.8.1 Company Overview 60
6.9 B. Braun Melsungen AG 60
6.9.1 Company Overview 60
6.10 Hospira, Inc. 61
6.10.1 Company Overview 61
6.11 JMS CO., LTD. 61
6.11.1 Company Overview 61
6.12 Smiths Medical 61
6.12.1 Company Overview 61
6.13 CareFusion Corporation 62
6.13.1 Company Overview 62
6.14 Cardinal Health, Inc. 62
6.14.1 Company Overview 62
6.15 Novartis AG 63
6.15.1 Company Overview 63

7 Drug Delivery Devices Market Pipeline Products 64

8 Financial Deals Landscape 70
8.1 Partnerships 70
8.1.1 Milestone Scientific Enters Into Joint Venture With China National Medicines And YiChang Humanwell Pharmaceutical 70
9 Recent Developments 71
9.1 Product News 71
9.1.1 Mar 26, 2010: Milestone Forms Alliance With Sinopharm For SFDA Approval Of STA System 71

10 Appendix 72
10.1 Definitions of Markets Covered in the Report 73
10.1.1 Drug Delivery Devices 73
Infusion Pumps 73
Infusion Disposable Sets 73
10.2 Research Methodology 75
10.3 Secondary Research 75
10.4 Primary Research 76
10.5 Models 76
10.6 Forecasts 77
10.7 Expert Panels 77
10.8 GlobalData Consulting 77
10.9 Currency Conversion 78
10.10 Contact Us 78
10.11 Disclaimer 78

List of Tables

Table 1: Drug Delivery Devices, China, Overall Revenue ($m), 2002-2016 10
Table 2: Drug Delivery Devices Market, China, Category Contribution (%), 2009 12
Table 3: Drug Delivery Devices, China, Cross-Segment Analysis, 2002-2016 14
Table 4: Drug Delivery Devices, China, Overall Revenue ($m), Historic, 2002-2009 16
Table 5: Drug Delivery Devices, China, Overall Revenue ($m), Forecast, 2009-2016 18
Table 6: Drug Delivery Devices, China, Category Volume (Units), 2002-2016 19
Table 7: Drug Delivery Devices, China, Category Volume (Units), Historic, 2002-2009 20
Table 8: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2009-2016 21
Table 9: Drug Delivery Devices, China, Company Share by Revenue ($m), 2008-2009 23
Table 10:Infusion Systems Market, China, Category Contribution (%), 2009 26
Table 11:Infusion Systems, China, Revenue ($m) by Segment, Historic, 2002-2009 28
Table 12:Infusion Systems, China, Revenue ($m) by Segment, Forecast, 2009-2016 30
Table 13:Infusion Systems, China, Volume (Units) by Segment, Historic, 2002-2009 32
Table 14:Infusion Systems, China, Volume (Units) by Segment, Forecast, 2009-2016 34
Table 15:Infusion Systems, China, Average Price ($), Historic, 2002-2009 35
Table 16:Infusion Systems, China, Average Price ($), Forecast, 2009-2016 35
Table 17:Infusion Systems, China, Distribution Share by Revenue ($m), 2008-2009 36
Table 18:Infusion Systems, China, Company Share by Revenue ($m), 2008-2009 38
Table 19:Inhalation Systems Market, China, Category Contribution (%), 2009 41
Table 20:Inhalation Systems, China, Revenue ($m) by Segment, Historic, 2002-2009 43
Table 21:Inhalation Systems, China, Revenue ($m) by Segment, Forecast, 2009-2016 45
Table 22:Inhalation Systems, China, Volume (Units) by Segment, Historic, 2002-2009 47
Table 23:Inhalation Systems, China, Volume (Units) by Segment, Forecast, 2009-2016 49
Table 24:Inhalation Systems, China, Average Price ($), Historic, 2002-2009 50
Table 25:Inhalation Systems, China, Average Price ($), Forecast, 2009-2016 50
Table 26:Inhalation Systems, China, Distribution Share by Revenue ($m), 2008-2009 51
Table 27:Inhalation Systems, China, Company Share by Revenue ($m), 2008-2009 53
Table 28:Drug Delivery Devices Market Pipeline Products 64
Table 29:Milestone Scientific Enters Into Joint Venture With China National Medicines And YiChang Humanwell Pharmaceutical 70
Table 30:USD to Local Currency, China, Average Actual Rate 2002-2009 78

List of  Figures

Figure 1: Drug Delivery Devices, Market Segmentation 9
Figure 2: Drug Delivery Devices, China, Overall Revenue ($m), 2002-2016 10
Figure 3: Drug Delivery Devices Market, China, Revenue Mix ($m), 2009 11
Figure 4: Drug Delivery Devices Market, China, Category Contribution (%), 2009 12
Figure 5: Drug Delivery Devices, China, Cross-Segment Analysis, 2002-2016 13
Figure 6: Drug Delivery Devices, China, Overall Revenue ($m), Historic, 2002-2009 15
Figure 7: Drug Delivery Devices, China, Overall Revenue ($m), Forecast, 2009-2016 17
Figure 8: Drug Delivery Devices, China, Category Volume (Units), 2002-2016 19
Figure 9: Drug Delivery Devices, China, Category Volume (Units), Historic, 2002-2009 20
Figure 10:Drug Delivery Devices, China, Category Volume (Units), Forecast, 2009-2016 21
Figure 11:Drug Delivery Devices, China, Company Share (%), 2009 22
Figure 12:Infusion Systems, Market Segmentation 24
Figure 13:Infusion Systems Market, China, Revenue Mix ($m), 2009 25
Figure 14:Infusion Systems Market, China, Category Contribution (%), 2009 26
Figure 15:Infusion Systems, China, Revenue ($m) by Segment, Historic, 2002-2009 27
Figure 16:Infusion Systems, China, Revenue ($m) by Segment, Forecast, 2009-2016 29
Figure 17:Infusion Systems, China, Volume (Units) by Segment, Historic, 2002-2009 31
Figure 18:Infusion Systems, China, Volume (Units) by Segment, Forecast, 2009-2016 33
Figure 19:Infusion Systems, China, Company Share (%), 2009 37
Figure 20:Inhalation Systems, Market Segmentation 39
Figure 21:Inhalation Systems Market, China, Revenue Mix ($m), 2009 40
Figure 22:Inhalation Systems Market, China, Category Contribution (%), 2009 41
Figure 23:Inhalation Systems, China, Revenue ($m) by Segment, Historic, 2002-2009 42
Figure 24:Inhalation Systems, China, Revenue ($m) by Segment, Forecast, 2009-2016 44
Figure 25:Inhalation Systems, China, Volume (Units) by Segment, Historic, 2002-2009 46
Figure 26:Inhalation Systems, China, Volume (Units) by Segment, Forecast, 2009-2016 48
Figure 27:Inhalation Systems, China, Company Share (%), 2009 52
Figure 28:GlaxoSmithKline plc, Company Share (%),China Drug Delivery Devices Market, 2009 54
Figure 29:AstraZeneca PLC, Company Share (%),China Drug Delivery Devices Market, 2009 55
Figure 30:3M Health Care, Company Share (%),China Drug Delivery Devices Market, 2009 56
Figure 31:Baxter International Inc., Company Share (%),China Drug Delivery Devices Market, 2009 57
Figure 32:Fresenius Kabi AG, Company Share (%),China Drug Delivery Devices Market, 2009 58
Figure 33:Boehringer Ingelheim GmbH, Company Share (%),China Drug Delivery Devices Market, 2009 59